Mike Hennessy

Articles

FDA Ends Summer With Surge of Activity

September 13th 2015

The FDA closed out summer 2015 by taking action on several oncology drug applications, approving new indications and granting several priority reviews.

Moving the Meter

September 13th 2015

Although the progress made in the treatment of patients with lung cancer has by now become a familiar story, it certainly bears repeating.

Bringing a Runaway Government Program to Heel

September 13th 2015

The 340B drug discount program is bigger than any Jurassic Park monster that ever broke out of its cage, and arguably bigger than any California wildfire that ever burned up the Sierras.

World GI Congress: New Data, New Hope

August 21st 2015

Several studies presented at the 2015 ESMO World Congress on Gastrointestinal Cancer offered new promise for patients.

Outside the Comfort Zone

August 21st 2015

For oncology specialists, caring for patients with cancer has long meant analyzing the biological and clinical pieces of a puzzle unique to each individual and then figuring out the optimal management plan to meet his or her needs.

Tradition of Greatness Continues With 3rd Annual Giants Class

July 21st 2015

It has been our privilege to salute those who have contributed so richly to the remarkable ongoing progress in oncology.

The Immuno Learning Curve

July 21st 2015

With two drugs on the market and more agents in the pipeline, there's little doubt that immunotherapies targeting the PD-1/PD-L1 pathway will become a backbone of oncology treatment in the near future, perhaps replacing chemotherapy in some malignancies.

No Consistency in Value Ascribed to Medical Scribes

July 20th 2015

The rise of electronic medical reporting and value-based standards and measures for improved medical care is supported by the best of intentions, but the implication is that physicians now spend more time behind the computer terminal and less time with patients.

Value Debate Turns to Drug Pricing

June 22nd 2015

Physicians have shown they don't have to be quiet participants in the value argument that is raging in oncologic circles.

Celebrating Greatness

June 20th 2015

One of the most gratifying aspects of working in the oncology information field is the opportunity we have to interact with the scientists and clinicians who are seeking to advance the care of patients with cancer.

Late-Stage Studies Star at ASCO 2015

June 20th 2015

Another ASCO annual meeting has come and gone, and now comes the fun part where we digest and interpret the significance of the mountains of new data presented.

Urology Practice and Specialty Pharmacy Meet at a Crossroads

June 15th 2015

In the oncology realm, specialty pharmacy has become a mainstay, but its role in urology practice is starting to trend upwards.

Zarxio Gets a Boston Welcome

June 2nd 2015

The road to becoming the first biosimilar to go on sale in the United States has been uneven for Zarxio (filgrastim-sndz), a Sandoz product for raising white blood cell counts.

Declaring Our Objectives in This Inaugural Issue

June 1st 2015

As we embark on this inaugural issue of Contemporary Radiation Oncology, it occurs to me that the launch of every new journal is always made with the best intentions.

Checkpoint Inhibitors Shine Across Tumor Types at AACR

May 26th 2015

Immune checkpoint blockade strategies were a central focus of much of the key data presented at AACR.

The Prostate Puzzle

May 20th 2015

During the past five years, the progress in therapeutic options for men with prostate cancer has been truly remarkable.

Reforms May Bring Radical Change

May 15th 2015

Competitive pressures and profound marketplace changes are a fact of life for the oncology business, and for a practice in San Antonio, Texas, that handles a large population of rural poor, planning sessions routinely involve discussions on how to stay independent and continue doing things the way physicians there feel is best.

BRCA Questions Resound

April 26th 2015

Given the higher risk of breast and ovarian cancer in BRCA mutation carriers, should broader screening for the abnormality be implemented?

Practices Hammered by Rising Uncertainty

April 15th 2015

The rise of high-deductible health plans has been accelerated by the Affordable Care Act, yet for many oncology practices this trend adds to the administrative workload and creates deep uncertainty on the accounts receivable side.

Prostate Cancer Coverage Extends Beyond Clinical Studies

April 9th 2015

It seems like the feature stories and meetings coverage this month singularly revolve around prostate cancer.